Cargando…

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma

BACKGROUND: Guidelines recommend thromboprophylaxis for patients with multiple myeloma (MM) at high risk for venous thromboembolism (VTE). However, the optimal risk prediction model for VTE in MM remains unclear. Khorana et al developed a VTE risk score (Khorana score) in ambulatory cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanfilippo, Kristen M., Carson, Kenneth R., Wang, Tzu‐Fei, Luo, Suhong, Edwin, Natasha, Kuderer, Nicole, Keller, Jesse M., Gage, Brian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742966/ https://www.ncbi.nlm.nih.gov/pubmed/35028491 http://dx.doi.org/10.1002/rth2.12634

Ejemplares similares

Venous thromboembolism in multiple myeloma is associated with increased mortality
por: Schoen, Martin W., et al.
Publicado: (2020)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
por: Akasaka-Kihara, Fumie, et al.
Publicado: (2021)

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
por: Piver, Rachael N., et al.
Publicado: (2023)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
por: Mulder, Frits I., et al.
Publicado: (2019)

Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
por: Overvad, Thure Filskov, et al.
Publicado: (2022)

Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
por: Rupa-Matysek, Joanna, et al.
Publicado: (2017)

Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
por: Khorana, Alok A., et al.
Publicado: (2020)

Retrospective Cohort Study of Venous Thromboembolism Rates in Ambulatory Cancer Patients: Association With Khorana Score and Other Risk Factors
por: Austin, Keziah, et al.
Publicado: (2019)

Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies
por: Ramos-Esquivel, Allan, et al.
Publicado: (2022)

Validation of the Khorana Score to Assess Venous Thromboembolism and Its Association with Mortality in Cancer Patients: A Retrospective Community-based Observational Experience
por: Ahmed, Gulrayz, et al.
Publicado: (2020)

Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
por: Choi, Yeo Jin, et al.
Publicado: (2021)

Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data
por: Tsubata, Yukari, et al.
Publicado: (2022)

OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients
por: López Jiménez, C., et al.
Publicado: (2021)

The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study
por: Overvad, Thure F., et al.
Publicado: (2022)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma
por: Vathiotis, Ioannis, et al.
Publicado: (2018)

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
por: Barni, Sandro, et al.
Publicado: (2020)

Corrigendum to “Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial”
Publicado: (2020)

Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience
por: Mirza, Abu-Sayeef, et al.
Publicado: (2019)

Har Gobind Khorana (1922–2011): Pioneering Spirit
por: Sakmar, Thomas P.
Publicado: (2012)

A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer
por: Chen, Ying, et al.
Publicado: (2021)

Evaluation of the Khorana Predictive Thrombotic Risk and Thromboprophylaxis Score in Cancer Patients in a Third Level Hospital
por: Bermejo, Lara Almudena Fernández, et al.
Publicado: (2022)

Venous Thromboembolism Risk Score and Pregnancy
por: Raia-Barjat, Tiphaine, et al.
Publicado: (2022)

Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
por: Ha, Hyerim, et al.
Publicado: (2023)

S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023)

Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
por: Barrett, Aisling, et al.
Publicado: (2021)

Nursing management of treatment-related venous thromboembolism in patients with multiple myeloma
por: Yang, Bianhong, et al.
Publicado: (2023)

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
por: Alp Kirkizlar, Tugcan, et al.
Publicado: (2023)

My remembrances of H.G. Khorana: exploring the mechanism of bacteriorhodopsin with site-directed mutagenesis and FTIR difference spectroscopy
por: Rothschild, Kenneth J.
Publicado: (2023)

Learning from Gobind Khorana: “The difficult we do today, the impossible tomorrow”
por: Subramaniam, Sriram
Publicado: (2022)

Expression systems for bovine rhodopsin: a review of the progress made in the Khorana laboratory
por: Reeves, Philip J.
Publicado: (2023)

The ICU-venous thromboembolism score and tumor grade can predict inhospital venous thromboembolism occurrence in critical patients with tumors
por: Mei, Ruqi, et al.
Publicado: (2022)

Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma
por: Brown, Joshua D., et al.
Publicado: (2016)

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment
por: Groat, Danielle, et al.
Publicado: (2022)

Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study
por: Zhang, Yu-Feng, et al.
Publicado: (2023)

A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score
por: Norris, Lucy A., et al.
Publicado: (2020)

Multilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment
por: Soria, José Manuel, et al.
Publicado: (2014)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Neonatal Venous Thromboembolism
por: Haley, Kristina M.
Publicado: (2017)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cbk5o2vtvu8uouqrsni4n5hlgg